Accelerating the delivery of cancer care at home during the Covid-19 pandemic
AI Laughlin, M Begley, T Delaney, L Zinck… - … Innovations in Care …, 2020 - catalyst.nejm.org
Penn Medicine's Cancer Care at Home program, established to address clinical,
administrative, and financial obstacles to delivering certain cancer drugs at home, enabled …
administrative, and financial obstacles to delivering certain cancer drugs at home, enabled …
Effects of a comprehensive reservation service for non-emergency registration on appointment registration rate, patient waiting time, patient satisfaction and outpatient …
W Xie, X Yang, X Cao, P Liu - BMC health services research, 2019 - Springer
Abstract Background In China, a long waiting time for registration is a common occurrence in
many tertiary hospitals. This study aimed to analyze the effects of a comprehensive …
many tertiary hospitals. This study aimed to analyze the effects of a comprehensive …
Community-based intravenous treatment and central venous access devices: a scoping review of the consumer and caregiver experience, information preferences …
Purpose Map existing research and describe the consumer/caregiver experience of
community-based intravenous treatment, central venous access devices (CVADs) …
community-based intravenous treatment, central venous access devices (CVADs) …
[HTML][HTML] The use of smartphone-based triage to reduce the rate of outpatient error registration: Cross-sectional study
W Xie, X Cao, H Dong, Y Liu - JMIR mHealth and uHealth, 2019 - mhealth.jmir.org
Background: In many clinics, patients now have the option to make Web-based
appointments but doing so according to their own judgment may lead to wrong registration …
appointments but doing so according to their own judgment may lead to wrong registration …
Patient safety and satisfaction in home chemotherapy
JM Sanguinetti, D Martínez, F Dimase… - Home Healthcare …, 2021 - journals.lww.com
Chemotherapy is increasingly being administered in patients' homes, improving quality of
life and patient comfort as well as reducing use of inpatient facilities and costs. This article …
life and patient comfort as well as reducing use of inpatient facilities and costs. This article …
A call for transplant stewardship: The need for expanded evidence‐based evaluation of induction and biologic‐based cost‐saving strategies in kidney transplantation …
MR Jorgenson, JL Descourouez, BL Brady… - Clinical …, 2021 - Wiley Online Library
Rising expenditures threaten healthcare sustainability. While transplant programs are
typically considered profitable, transplant medications are expensive and frequently targeted …
typically considered profitable, transplant medications are expensive and frequently targeted …
Successful implementation of outpatient R±DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience
TK Pak, BN Dixon, MJ Buege, PH Dao… - Leukemia & …, 2022 - Taylor & Francis
R±DHAX has been traditionally administered to inpatient due to the timing of chemotherapy
administration and the perceived need for close monitoring of adverse effects. To administer …
administration and the perceived need for close monitoring of adverse effects. To administer …
Evaluation of adverse events and health‐related quality of life in patients with colorectal cancer receiving ambulatory home‐based chemotherapy in Thailand
S Sirilerttrakul, N Wannakansophon, P Utthiya… - Nursing …, 2021 - Wiley Online Library
Aims To compare adverse events and health‐related quality of life in ambulatory home‐
based chemotherapy with those in inpatient. Design Prospective non‐randomized …
based chemotherapy with those in inpatient. Design Prospective non‐randomized …
Safety and financial analysis of outpatient dose-adjusted EPOCH for B-cell lymphoma at a tertiary comprehensive cancer center
W Li, KA Richter, KA Tobon… - Journal of Oncology …, 2021 - journals.sagepub.com
Introduction Dose-adjusted (DA-) EPOCH (etoposide, prednisone, vincristine,
cyclophosphamide, doxorubicin) is a front-line treatment option for aggressive B-cell …
cyclophosphamide, doxorubicin) is a front-line treatment option for aggressive B-cell …
Pediatric Cancer and the Cost of Hope
T Andre'Campbell - 2023 - search.proquest.com
The concept of hope is well known to the medical community, but how hope and prospect of
outcomes impact financial and treatment decision making on the part of the …
outcomes impact financial and treatment decision making on the part of the …